Navigation Links
Cell Genesys to Present at the Cowen and Company and the Lehman Brothers Healthcare Investor Conferences
Date:3/11/2008

SOUTH SAN FRANCISCO, Calif., March 11 /PRNewswire-FirstCall/ -- Cell Genesys, Inc. (Nasdaq: CEGE) today announced that Sharon E. Tetlow, senior vice president and chief financial officer of Cell Genesys, will present a company update on Tuesday, March 18 at 8:00 a.m. ET at the Cowen and Company 28th Annual Healthcare Conference in Boston, Massachusetts. Stephen A. Sherwin, chairman and chief executive officer of Cell Genesys, will present a company update on March 18 at 10:15 a.m. ET at the Lehman Brothers 11th Annual Global Healthcare Conference in Miami, Florida.

A live audio webcast of both presentations will be accessible through the Investor Relations section of the Cell Genesys website, http://www.cellgenesys.com. If you are unable to listen to the live webcast, it will be archived on the site for at least 72 hours following the presentation. To access the replay, go to the Investor Relations section of the website.

Cell Genesys is focused on the development and commercialization of novel biological therapies for patients with cancer. The company is currently pursuing two clinical stage product platforms -- GVAX(TM) cancer immunotherapies and oncolytic virus therapies. Ongoing clinical trials include Phase 3 trials of GVAX immunotherapy for prostate cancer, Phase 2 trials of GVAX immunotherapies for pancreatic cancer and for leukemia, and a Phase 1 trial of CG0070 oncolytic virus therapy for bladder cancer. Cell Genesys continues to hold an equity interest in its former subsidiary, Ceregene, Inc., which is developing gene therapies for neurodegenerative disorders. Cell Genesys is headquartered in South San Francisco, CA and has its principal manufacturing operation in Hayward, CA. For additional information, please visit the company's website at http://www.cellgenesys.com.

Contact:

Susan Ferris

Investor Relations

650-266-3200


'/>"/>
SOURCE Cell Genesys, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Cell Genesys Reports Fourth Quarter and Year-End 2007 Results
2. Brookdale to Present at Citi Small & Mid-Cap Conference on March 17
3. Schering-Plough to Webcast Presentation by CEO Fred Hassan at Lehman Brothers Eleventh Annual Global Healthcare Conference
4. Medco to Present at Cowen and Company and Lehman Brothers Health Care Conferences
5. Gentiva(R) Health Services to Present March 18th at Lehman Brothers Eleventh Annual Global Healthcare Conference in Miami
6. Thermo Fisher Scientific to Present at 11th Annual Lehman Brothers Global Healthcare Conference
7. AMN Healthcare Services to Present at the Lehman Brothers 11th Annual Global Healthcare Conference
8. Cowen & Company 28th Annual Healthcare Conference to Webcast Millennium Presentation
9. NBTY to Webcast Presentation at Bank of America Consumer Conference: Announces Preliminary Sales and the Repurchase of 6.1 Million Shares
10. Bi-Partisan Members of U.S. House of Representatives Formally Oppose Funding Reductions to Medicares Home Oxygen Benefit
11. Novavax CEO to Present at the Partnering for Global Health Forum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2017)... ... , ... Alcovit, a lime-flavored beverage that rids the body of toxins linked ... now available through Jet.com. , After 25 years of development, the company released ... to quickly detox the body thereby avoiding alcohol-induced hangovers. Whether you’re having fun with ...
(Date:8/18/2017)... ... August 18, 2017 , ... “Dangerous Inheritance”: a mystery about saving the family ... is from Southwest Nebraska where she was raised on a farm. As Diane ... is fictional, but the friendships and mantra of ‘neighbors helping neighbors’ have always been ...
(Date:8/18/2017)... ... August 18, 2017 , ... Rollon Skin ... anti-aging skincare solutions, recently announced the launch of two new skincare products, ... yet effective alternative to expensive plastic surgery or in-patient cosmetic dermatological procedures. , ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... the Coatesville Veterans Affairs Medical Center. “Case #10-5411 Veterans Administration” is the ... of domestic abuse. In June 1990, Carol Mulhem started work at the ...
(Date:8/17/2017)... , ... August 17, 2017 , ... When Amy ... stretcher side nurse, she took with her a dream to make nursing education more ... Specifically, ensuring communication skills were integrated into healthcare provider education. , ...
Breaking Medicine News(10 mins):
(Date:8/8/2017)... Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical company focused on ... the second quarter ended June 30, 2017. ... to date: Continued ... lead project, BL-8040: Announced plans to ... stem cell mobilization treatment for autologous bone-marrow transplantation in ...
(Date:8/7/2017)... -- Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation,s largest independent specialty ... 2017.  All comparisons, unless otherwise noted, are to the quarter ... Second Quarter 2017 Highlights include: ... of 3.5% Total prescriptions dispensed of 220,000, ... versus 7.6% Gross profit per prescription ...
(Date:8/2/2017)... 2, 2017 Fenita J. Caldwell ... a Pinnacle Lifetime Professional in the Field of ... at Turing Pharmaceuticals, AG. Her skills and areas ... building.                ... years of experience as a highly successful sales ...
Breaking Medicine Technology: